Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02380716 · ClinicalTrials.gov registry record
ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection
A clinical trial of Aortic Dissection, sponsored by W.L.Gore & Associates.
- Active
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT02380716 is a study of Aortic Dissection that is active but no longer recruiting, run by W.L.Gore & Associates. The registered enrollment target is 21 participants, below the 662-participant average among 11 other Aortic Dissection trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02380716, a study of Aortic Dissection, is active but no longer recruiting, sponsored by W.L.Gore & Associates.
- ACTIVE NOT RECRUITING
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess the feasibility of the treatment of DeBakey Type I/II aortic dissections with the GORE® Ascending Stent Graft
Conditions Studied
Interventions
- DEVICE GORE® Ascending Stent Graft
Study Locations (1)
California
- University of Southern California- Keck Medicine - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-08 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02380716
The ClinicalTrials.gov registry entry for NCT02380716 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 662-participant average among 11 other Aortic Dissection trials with a reported enrollment target (97% lower). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Dissection appearing as the primary indexed condition, and to 1 intervention - of which GORE® Ascending Stent Graft is the first listed.
NCT02380716 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02380716 about?
NCT02380716 is a clinical study titled "ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection". Assess the feasibility of the treatment of DeBakey Type I/II aortic dissections with the GORE® Ascending Stent Graft
What is the current status of trial NCT02380716?
This trial is currently active not recruiting. The enrollment target is 21 participants. The study started on 2015-08. Estimated completion is 2026-04.
What conditions does trial NCT02380716 study?
This clinical trial studies the following conditions: Aortic Dissection.
What interventions are being tested in trial NCT02380716?
The interventions under investigation include: GORE® Ascending Stent Graft (DEVICE).
Who is sponsoring clinical trial NCT02380716?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02380716 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Dissection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiovascular Health Improvement Project
RECRUITING
-
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
RECRUITING · NA
-
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
RECRUITING · NA
-
Feasibility of Endovascular Repair Of Ascending Aortic Pathologies
RECRUITING · NA
-
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
RECRUITING
-
Valved Graft PMCF Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.